114 related articles for article (PubMed ID: 315126)
1. [Ocular complications after treatment with antimalarial agents in dermatology].
Mikkelsen J
Ugeskr Laeger; 1979 Aug; 141(34):2316-8. PubMed ID: 315126
[No Abstract] [Full Text] [Related]
2. Antimalarials for children: indications, toxicities, and guidelines.
Ziering CL; Rabinowitz LG; Esterly NB
J Am Acad Dermatol; 1993 May; 28(5 Pt 1):764-70. PubMed ID: 8496422
[TBL] [Abstract][Full Text] [Related]
3. [Chloroquine and hydroxychloroquine dosage in juvenile rheumatoid arthritis].
Laaksonen AL; Koskiahde V; Juva K
Duodecim; 1974; 90(2):125-31. PubMed ID: 4848261
[No Abstract] [Full Text] [Related]
4. Keratopathy with low dose chloroquine therapy.
Cullen AP; Chou BR
J Am Optom Assoc; 1986 May; 57(5):368-72. PubMed ID: 3711574
[TBL] [Abstract][Full Text] [Related]
5. Antimalarial drug-induced aquagenic-type pruritus in patients with lupus.
Jiménez-Alonso J; Tercedor J; Jáimez L; García-Lora E
Arthritis Rheum; 1998 Apr; 41(4):744-5. PubMed ID: 9550488
[No Abstract] [Full Text] [Related]
6. Ocular damage in chloroquine therapy.
Nylander U
Acta Ophthalmol (Copenh); 1967; ():Suppl 92:1-71. PubMed ID: 4866642
[No Abstract] [Full Text] [Related]
7. Dosage of antimalarial drugs for children with juvenile rheumatoid arthritis and systemic lupus erythematosus. A clinical study with determination of serum concentrations of chloroquine and hydroxychloroquine.
Laaksonen AL; Koskiahde V; Juva K
Scand J Rheumatol; 1974; 3(2):103-8. PubMed ID: 4608161
[No Abstract] [Full Text] [Related]
8. [Treatment of juvenile rheumatoid arthritis with chloroquine phosphate and hydroxychloroquine sulphate. Dosage of syrup and tablets with determinations of serum concentrations].
Laaksonen AL; Sunell JE; Juva K
Nord Med; 1971 Mar; 85(12):362-8. PubMed ID: 5574957
[No Abstract] [Full Text] [Related]
9. [Side effects of the long-term treatment of skin diseases with corticosteroids].
Starzycki Z; Dembińska B
Przegl Dermatol; 1983; 70(4):423-8. PubMed ID: 6669715
[No Abstract] [Full Text] [Related]
10. Antimalarial therapy in SLE.
Lanham JG; Hughes GR
Clin Rheum Dis; 1982 Apr; 8(1):279-98. PubMed ID: 6749400
[No Abstract] [Full Text] [Related]
11. [Corneal lesions of the "whirling dystrophy" kind during treatment with chloroquine salt].
Bonnet I; Dorne PA
Bull Soc Ophtalmol Fr; 1970 Apr; 70(4):533-4. PubMed ID: 5312147
[No Abstract] [Full Text] [Related]
12. [Chloroquine and hydroxychloroquine: side effect profile of important therapeutic drugs].
Ochsendorf FR; Runne U
Hautarzt; 1991 Mar; 42(3):140-6. PubMed ID: 2055762
[TBL] [Abstract][Full Text] [Related]
13. The prescribing of chloroquine and hydroxychloroquine by consultant rheumatologists in the UK.
Kay EA; Rees JA; Jayson MI
Br J Rheumatol; 1987 Oct; 26(5):375-8. PubMed ID: 3664163
[TBL] [Abstract][Full Text] [Related]
14. An ophthalmological view on the efficacy and safety of chloroquine versus hydroxychloroquine.
Easterbrook M
J Rheumatol; 1999 Sep; 26(9):1866-8. PubMed ID: 10493662
[No Abstract] [Full Text] [Related]
15. A rheumatologist's verdict on the safety of chloroquine versus hydroxychloroquine. Liability in off-label prescribing.
Houpt JB
J Rheumatol; 1999 Sep; 26(9):1864-6. PubMed ID: 10493661
[No Abstract] [Full Text] [Related]
16. [Chloroquine retinopathy: avoidable by individualized daily dosing].
Ochsendorf FR; Runne U; Goerz G; Zrenner E
Dtsch Med Wochenschr; 1993 Dec; 118(51-52):1895-8. PubMed ID: 8287780
[No Abstract] [Full Text] [Related]
17. Antimalarial treatment of rheumatoid arthritis: 1985 status.
Rynes RI
J Rheumatol; 1985 Aug; 12(4):657-9. PubMed ID: 4057186
[No Abstract] [Full Text] [Related]
18. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
Aylward JM
J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
[TBL] [Abstract][Full Text] [Related]
19. Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.
Fox RI; Dixon R; Guarrasi V; Krubel S
Lupus; 1996 Jun; 5 Suppl 1():S31-6. PubMed ID: 8803908
[TBL] [Abstract][Full Text] [Related]
20. [Eye toxicity of antimalarial agents].
Graña Gil J; Cabana Vázquez M; Vázquez González A; Sánchez Meizoso MO
An Med Interna; 2002 Apr; 19(4):189-91. PubMed ID: 12090061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
